176
Participants
Start Date
September 1, 2019
Primary Completion Date
December 1, 2027
Study Completion Date
December 1, 2027
esophagectomy
esophagectomy with at least two-field (thoracic-abdominal) lymphadenectomy
chemoradiation
concurrent chemotherapy and radiotherapy
active surveillance
No further adjuvant therapy
ACTIVE_NOT_RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
ACTIVE_NOT_RECRUITING
Changhai Hospital, The Second Military Medical University, Shanghai
ACTIVE_NOT_RECRUITING
Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai
RECRUITING
Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai
ACTIVE_NOT_RECRUITING
Zhongshan Hospital, Fudan University, Shanghai
ACTIVE_NOT_RECRUITING
Tianjin Medical University Cancer Institute and Hospital, Tianjin
Shanghai Chest Hospital
OTHER